MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tremors: Treatment"

  • 2025 International Congress

    A Systematic Review of Motor Improvement Caused by Deep Brain Stimulation in Post-Stroke Movement Disorder Patients

    AJ. Ribeiro, L. Koehler, MF. Felippe, J. Lopes, G. Sorato, G. Maia, V. Xavier, AC. Petry, M. da Rosa, M. Neto, CR. Rieder (Porto Alegre, Brazil)

    Objective: Evaluate the effect of DBS on motor improvement in PSMD. Background: Post-stroke movement disorders (PSMD) impair motor function and quality of life. Traditional rehabilitation…
  • 2025 International Congress

    Equity in Access to MRI-Guided Focused Ultrasound for Movement Disorders: Patient Characteristics and Treatment Disposition

    M. Park, D. Gonzalez, N. Pertsch, K. Sakakura, C. Swan, M. Wodziak, D. Ulrich, A. Karstens (Chicago, USA)

    Objective: To probe the characteristics of individuals undergoing MRI-guided focused ultrasound (MRgFUS). Background: MRgFUS has emerged as a non-invasive treatment that alleviates tremor through targeted…
  • 2025 International Congress

    A Snapshot on Advanced Therapies in Essential Tremor: Insights from a Neurology Survey

    A. Sanchez Fraga, L. Knight, R. Martuscello, C. Tengelin, P. Crivelli, K. Gant, C. Ferrer, A. Grinspan (Munich, Germany)

    Objective: To explore whether recent developments in Essential Tremor (ET) and new advanced therapies have influenced clinical practice. Background: Recent advancements in the understanding of…
  • 2025 International Congress

    A Comparison of Coordinated Reset and Low-Frequency Vibrotactile Stimulation for the Treatment of Parkinson’s Symptoms

    E. Kabasenche, M. Gutierrez, M. Fisher, C. Hauptmann, P. Luu, D. Tucker (Eugene, USA)

    Objective: This research examines a novel non-invasive vibrotactile device which stimulates fingertips in a pattern aiming to disrupt pathological physiological beta-band oscillations believed to be…
  • 2025 International Congress

    Adaptive deep brain stimulation for tremor control in Parkinson’s disease

    A. Ramirez-Zamora, T. Herrington, M. Beudel, J. Ostrem, S. Little, L. Almeida, A. Fasano, T. Hassell, K. Mitchell, E. Moro, M. Gostkowski, N. Sarangmat, L. Tonder, Y. Tan, R. Summers, N. Morelli, H. Bronte-Stewart (Gainesville, USA)

    Objective: To evaluate clinical improvements in tremor following the implementation of adaptive deep brain stimulation (aDBS). Background: Alpha-beta (8-30Hz) based aDBS is a safe and…
  • 2024 International Congress

    Essential3: An Innovative Multi-Study Phase 3 Program to Evaluate the Efficacy and Safety of Ulixacaltamide

    R. Able, M. Giroux, J. Zhao, H. Jacotin, M. Sniecinski, A. Samaroo, A. La Croix, A. Wyant, C. Santos, M. Souza (Boston, USA)

    Objective: An innovative, multi-study Phase 3 program to definitively assess safety and efficacy of ulixacaltamide in essential tremor (ET). Background: Phase 2 studies of ulixacaltamide,…
  • 2024 International Congress

    Magnetic resonance-guided focused ultrasounds (MRgFUS) thalamotomy for disabling tremor secondary to multiple sclerosis.

    A. Menéndez, L. Ispierto, M. Tardaguila, J. Muñoz, C. Ramo-Tello, A. González, R. Alvarez, D. Vilas (Badalona, Spain)

    Objective: To describe two patients with disabling tremor secondary to multiple sclerosis (MS) treated with magnetic resonance-guided focused ultrasounds (MRgFUS) thalamotomy. Background: MRgFUS thalamotomy improves…
  • 2024 International Congress

    Istradefylline effects on L-Dopa resistant tremor in Parkinson’s disease

    G. Ozay, I. Zhang, M. Umali, L. Lovelace, M. Barry, L. Ariza Serrano, A. Sharma, L. Raslan, Y. Torres-Yaghi, F. Pagan (Washington, USA)

    Objective: Quantifying Istradefylline(IST) effects in L-Dopa(LD) resistant tremor in Parkinson’s disease(PD) patients. Background: The adenosine A2A receptors control the indirect pathway. Adenosine A2A receptor activation decreases…
  • 2024 International Congress

    Assessing the Economic Impact of Transcutaneous Afferent Patterned Stimulation Therapy for Essential Tremor: A Real-World Evidence Study Protocol

    D. Dai, J. Fernandes, L. Samuel, C. Lu, S. Reitmaier, A. Berk (Woonsocket, USA)

    Objective: To assess differences in healthcare resource utilization (HCRU) and costs between patients with essential tremor (ET) receiving transcutaneous afferent patterned stimulation (TAPS) therapy and…
  • 2024 International Congress

    MR-guided focused ultrasound for essential tremor: exploratory analysis comparing unilateral and staged, bilateral thalamotomy

    HM. Eisenberg, P. Fishman, P. Ghanouni, M. Grassman, C. Ferrer, K. Gant, A. Grinspan (Baltimore, USA)

    Objective: This exploratory analysis investigated tremor-motor (TM) outcomes in patients receiving unilateral versus staged, bilateral magnetic resonance-guided focused ultrasound (MRgFUS) VIM thalamotomy for essential tremor…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 17
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley